Four cycles of docetaxel and cyclophosphamide as adjuvant …
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475113/
WebAug 13, 2020 · The US Oncology (USON) 9735 trial compared four cycles of doxorubicin and cyclophosphamide (AC) with four cycles of DC in patients with resected stage I to III breast cancer . Disease free survival (DFS) at a median follow-up of 5.5 years, and subsequently overall survival (OS) after 7-years follow-up, were superior with four cycles …
DA: 33 PA: 40 MOZ Rank: 34